Literature DB >> 32129110

The role of xenobiotic-metabolizing enzymes in the placenta: a growing research field.

Ricardo Blanco-Castañeda1, Carlos Galaviz-Hernández1, Paula C S Souto2, Victor Vitorino Lima2, Fernanda R Giachini2, Carlos Escudero3, Alicia E Damiano4,5, L Jazel Barragán-Zúñiga1, Gerardo Martínez-Aguilar6, Martha Sosa-Macías1.   

Abstract

Introduction: The placenta is a temporary and unique organ that allows for the physical connection between a mother and fetus; this organ regulates the transport of gases and nutrients mediating the elimination of waste products contained in the fetal circulation. The placenta performs metabolic and excretion functions, on the basis of multiple enzymatic systems responsible for the oxidation, reduction, hydrolysis, and conjugation of xenobiotics. These mechanisms give the placenta a protective role that limits the fetal exposure to harmful compounds. During pregnancy, some diseases require uninterrupted treatment even if it is detrimental to the fetus. Drugs and other xenobiotics alter gene expression in the placenta with repercussions for the fetus and mother's well-being.Areas covered: This review provides a brief description of the human placental structure and function, the main drug and xenobiotic transporters and metabolizing enzymes, placenta-metabolized substrates, and alterations in gene expression that the exposure to xenobiotics may cause.Expert opinion: Research should be focused on the identification and validation of biological markers for the assessment of the harmful effects of some drugs in pregnancy, including the evaluation of polymorphisms and methylation patterns in chorionic villous samples and/or amniotic fluid.

Entities:  

Keywords:  CYP450 enzyme; drug; gene expression; placenta; placental metabolism; pregnancy; transport protein

Mesh:

Substances:

Year:  2020        PMID: 32129110     DOI: 10.1080/17512433.2020.1733412

Source DB:  PubMed          Journal:  Expert Rev Clin Pharmacol        ISSN: 1751-2433            Impact factor:   5.045


  4 in total

1.  A review of ex vivo placental perfusion models: an underutilized but promising method to study maternal-fetal interactions.

Authors:  Pinar Calis; Lucia Vojtech; Florian Hladik; Michael G Gravett
Journal:  J Matern Fetal Neonatal Med       Date:  2021-11-24

2.  Gestational Age-Dependent Abundance of Human Placental Transporters as Determined by Quantitative Targeted Proteomics.

Authors:  Olena Anoshchenko; Bhagwat Prasad; Naveen K Neradugomma; Joanne Wang; Qingcheng Mao; Jashvant D Unadkat
Journal:  Drug Metab Dispos       Date:  2020-06-26       Impact factor: 3.922

Review 3.  Overview of Drug Transporters in Human Placenta.

Authors:  Michiko Yamashita; Udo R Markert
Journal:  Int J Mol Sci       Date:  2021-12-05       Impact factor: 5.923

Review 4.  The Pivotal Role of the Placenta in Normal and Pathological Pregnancies: A Focus on Preeclampsia, Fetal Growth Restriction, and Maternal Chronic Venous Disease.

Authors:  Miguel A Ortega; Oscar Fraile-Martínez; Cielo García-Montero; Miguel A Sáez; Miguel Angel Álvarez-Mon; Diego Torres-Carranza; Melchor Álvarez-Mon; Julia Bujan; Natalio García-Honduvilla; Coral Bravo; Luis G Guijarro; Juan A De León-Luis
Journal:  Cells       Date:  2022-02-06       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.